Zobrazeno 1 - 10
of 107
pro vyhledávání: '"K. L.G. Spindler"'
Autor:
Olav Dajani, Elin H. Kure, Per Pfeiffer, Bengt Glimelius, K. L.G. Spindler, Halfdan Sorbye, Ole Christian Lingjærde, Niels Pallisgaard, Tormod Kyrre Guren, Julian Hamfjord, Kjell Magne Tveit
Publikováno v:
International Journal of Cancer. 149:1385-1397
Detection of tumour-specific circulating cell-free DNA in plasma (ctDNA) fails in a significant number of cases depending on the clinical context. The primary aim was to investigate clinicopathological factors associated with detection of ctDNA in pa
Autor:
S.-B. Kim, Laetitia Dahan, Jaume Capdevila, Marwan Fakih, Lars Henrik Jensen, Chenwei Tian, K.-L.G. Spindler, Duncan C. Gilbert, Marianne Grønlie Guren, Sheela Rao, Dirk Arnold, T. Kayyal, J-P. Spano, A. Demols, Stefano Tamberi, M.J. Jones, M. Cornfeld, M. Catlett
Publikováno v:
Annals of Oncology. 31:S1170-S1171
Autor:
Elin H. Kure, Halfdan Sorbye, Kjell Magne Tveit, Niels Pallisgaard, Olav Dajani, K. L.G. Spindler, Ole Christian Lingjærde, Julian Hamfjord, Tormod Kyrre Guren, Per Pfeiffer, Bengt Glimelius, Julia S. Johansen
Publikováno v:
Hamfjord, J, Guren, T K, Dajani, O, Johansen, J S, Glimelius, B, Sorbye, H, Pfeiffer, P, Lingjærde, O C, Tveit, K M, Kure, E H, Pallisgaard, N & Spindler, K-L G 2019, ' Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 30, no. 7, pp. 1088-1095 . https://doi.org/10.1093/annonc/mdz139
Annals of Oncology
Hamfjord, J, Guren, T K, Dajani, O, Johansen, J S, Glimelius, B, Sorbye, H, Pfeiffer, P, Lingjærde, O C, Tveit, K M, Kure, E H, Pallisgaard, N & Spindler, K L G 2019, ' Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 30, no. 7, mdz139, pp. 1088-1095 . https://doi.org/10.1093/annonc/mdz139
Annals of Oncology
Hamfjord, J, Guren, T K, Dajani, O, Johansen, J S, Glimelius, B, Sorbye, H, Pfeiffer, P, Lingjærde, O C, Tveit, K M, Kure, E H, Pallisgaard, N & Spindler, K L G 2019, ' Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 30, no. 7, mdz139, pp. 1088-1095 . https://doi.org/10.1093/annonc/mdz139
BACKGROUND: Metastatic colorectal cancer (mCRC) is a heterogeneous disease where prognosis is dependent both on tumor biology and host factors. Total circulating cell-free DNA (cfDNA) has shown to harbor prognostic information in mCRC, although less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360d1d22c619f922ee55d965bc432fc4
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-394653
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-394653
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christina Demuth, Estrid Hoegdall, Julia S. Johansen, Benny V. Jensen, Per Pfeiffer, Boe Sandahl Sorensen, K. L.G. Spindler, Dorte Nielsen, Niels Pallisgaard
Publikováno v:
Tumor Biology, Vol 40 (2018)
Spindler, K-L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumor Biology, vol. 40, no. 11, pp. 1-8 . https://doi.org/10.1177/1010428318811207
Spindler, K-L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumor Biology, vol. 40, no. 11, 1010428318811207 . https://doi.org/10.1177/1010428318811207
Spindler, K L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 40, no. 11 . https://doi.org/10.1177/1010428318811207
Spindler, K-L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumor Biology, vol. 40, no. 11, pp. 1-8 . https://doi.org/10.1177/1010428318811207
Spindler, K-L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumor Biology, vol. 40, no. 11, 1010428318811207 . https://doi.org/10.1177/1010428318811207
Spindler, K L G, Demuth, C, Sorensen, B S, Johansen, J S, Nielsen, D, Pallisgaard, N, Hoegdall, E, Pfeiffer, P & Vittrup Jensen, B 2018, ' Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer ', Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 40, no. 11 . https://doi.org/10.1177/1010428318811207
In late-stage metastatic colorectal cancer, difficult treatment decisions should incorporate a thorough evaluation of the patient’s general condition and subject for shared decision making. Assessment of the individual patients’ prognosis is valu
Publikováno v:
Annals of Oncology. 30:iv61
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K.-L.G. Spindler, Mette Karen Yilmaz, Per Pfeiffer, Julia S. Johansen, Dorte Nielsen, Jakob Vasehus Schou, I.J. Christensen, Anders Jakobsen, Estrid Høgdall, Benny Vittrup Jensen
Publikováno v:
Jensen, B V, Spindler, K-L G, Christensen, I J, Schou, JV, Nielsen, D L, Jakobsen, A, Hogdall, E, Pfeiffer, P, Yilmaz, M K & Johansen, J 2016, ' Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan ', Annals of Oncology, vol. 27, no. Suppl. 6, 95P . https://doi.org/10.1093/annonc/mdw363.43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17dec164af2799e016481dfd8566a603
https://vbn.aau.dk/da/publications/f79167a2-8120-4b86-9ac4-9a37031a1ae4
https://vbn.aau.dk/da/publications/f79167a2-8120-4b86-9ac4-9a37031a1ae4
Autor:
Julia S. Johansen, Louise Skau Rasmussen, Svend Erik Nielsen, Christian Dehlendorff, N.H. Holländer, Niels Pallisgaard, K.-L.G. Spindler, Jon Kroll Bjerregaard, K.L. Wind, Per Pfeiffer, Stig E. Bojesen, Inna Chen, Astrid Z. Johansen, B Vittrup, Boe Sandahl Sorensen, Mette Karen Yilmaz
Publikováno v:
Chen, I, Wind, K L, Dehlendorff, C, Sørensen, B S, Vittrup, B V, Johansen, A, Pfeiffer, P, Bjerregaard, J K, Bojesen, S E, Nielsen, S E, Holländer, N H, Yilmaz, M K, Rasmussen, L S, Pallisgaard, N, Johansen, J S & Spindler, K-L G 2018, ' Clinical utility of plasma cell-free DNA in patients with pancreatic cancer ', Annals of Oncology, vol. 29, no. suppl_8, 715P, pp. vii241-vii242 . https://doi.org/10.1093/annonc/mdy282.098
Chen, I, Wind, K L, Dehlendorff, C, Sorensen, B S, Vittrup, B V, Johansen, A, Pfeiffer, P, Bjerregaard, J K, Bojesen, S E, Nielsen, S E, Hollander, N H, Yilmaz, M K, Rasmussen, L S, Pallisgaard, N, Johansen, J S & Spindler, K-L G 2018, ' Clinical utility of plasma cell-free DNA in patients with pancreatic cancer ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii241-viii242 . https://doi.org/10.1093/annonc/mdy282.098
Chen, I, Wind, K L, Dehlendorff, C, Sorensen, B S, Vittrup, B V, Johansen, A, Pfeiffer, P, Bjerregaard, J K, Bojesen, S E, Nielsen, S E, Hollander, N H, Yilmaz, M K, Rasmussen, L S, Pallisgaard, N, Johansen, J S & Spindler, K-L G 2018, ' Clinical utility of plasma cell-free DNA in patients with pancreatic cancer ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii241-viii242 . https://doi.org/10.1093/annonc/mdy282.098
Background: Reliable biomarkers in patients (pts) with pancreatic cancer (PC) are highly warranted. The aim of this prospective-retrospective biomarker study was to investigate the clinical value of cell-free DNA (cfDNA) in pts with PC.Methods: A tot